Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets (Parenthetical)

v3.25.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2025
Jun. 30, 2024
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 355,464 $ 398,809
Revenues in excess of billings, allowance $ 34,496 $ 116,148
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 500,000 500,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 18,000,000 18,000,000
Common stock, shares issued 12,700,465 12,359,922
Common stock, shares outstanding 11,761,434 11,420,891
Treasury stock, shares 939,031 939,031